A practical reference on nootropic: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-02-14 and is reviewed periodically as new material appears.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
| Property | Value | Notes |
|---|---|---|
| Principal proposed target | GABA-A receptor complex | Hypothesis derived mainly from animal pharmacology |
| Common behavioral assay | Elevated plus maze | Rodent test for anxiety-like behavior |
| Reported molecular marker | Hippocampal BDNF expression | Measured by immunoassay or mRNA quantification |
| Typical dosing route | Intranasal | Chosen to reduce first-pass metabolism |
| Reported plasma half-life | Minutes | Based on limited peptide stability data |
Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.
Reported activity for Selank centers on anxiolytic and nootropic effects. Russian clinical reports describe use in anxiety and in cognitive or attention-related complaints. Most of this evidence comes from studies conducted by the same research groups that developed the peptide. Independent replication in other countries remains limited, and no major Western regulatory agency has approved the compound for any indication. The gap between local reports and external verification is a recurring point in discussions of the peptide.
Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
== Evolutionary Biology == The following tables compare the Homo sapiens FGFR1OP2 gene and protein to orthologs. In both of the following tables, the divergence from the Homo sapiens FGFR1OP2 gene or protein to the ortholog was found using TimeTree. Ortholog mRNA and protein sequences were found using NCBI's BLAST and UCSC's BLAT Tool. The accession numbers, as well as the sequence length and the sequence similarity were compiled using BLAST.
== Management == As of 2019, no disease-modifying pharmaceuticals are known. Both strength and aerobic exercise have shown to be beneficial, although strenuous and excessive exercise should be avoided. Physical therapy can address contractures. Orthopedic surgery address foot deformities, scoliosis, Achilles tendon contractures, and winged scapula. Winged scapula can be addressed with either scapulopexy or scapulothoracic fusion. Circumstances to avoid include extremes of body weight, bone fractures, and prolonged immobility.
=== Microsoft === While at Harvard, Newell visited his brother at Microsoft, which was not yet a major software developer. At the suggestion of the Microsoft executive Steve Ballmer, he dropped out of Harvard and began working at Microsoft. Newell said later that Microsoft was the best place in the world to learn to program at the time. Newell spent 13 years at Microsoft as a programmer and technical executive, and produced the first three releases of the Windows operating system. In late 1995, Doom, a 1993 first-person shooter game developed by id Software, was estimated to be installed on more computers worldwide than Microsoft's new operating system, Windows 95. Newell said: "[id] ... didn't even distribute through retail, it distributed through bulletin boards and other pre-internet mechanisms. To me, that was a lightning bolt. Microsoft was hiring 500-people sales teams and this entire company was 12 people, yet it had created the most widely distributed software in the world. There was a sea change coming." At Microsoft, Newell led development on a port of Doom for Windows 95, which is credited with helping make Windows a viable game platform.
Sources: en.wikipedia.org
One study estimated that 10 square meters of oyster reef could enhance an ecosystem's biomass by 2.57 kg Herbivore shellfish will also be preyed on. This moves energy directly from primary producers to higher trophic levels potentially skipping out on multiple energetically costly trophic jumps which would increase biomass in the ecosystem. Seaweed farming is a carbon negative crop, with a high potential for climate change mitigation. The IPCC Special Report on the Ocean and Cryosphere in a Changing Climate recommends "further research attention" as a mitigation tactic. Regenerative ocean farming is a polyculture farming system that grows a mix of seaweeds and shellfish while sequestering carbon, decreasing nitrogen in the water and increasing oxygen, helping to regenerate and restore local habitat like reef ecosystems.
Napoleon succeeded in bringing the imperial forces in the region to around 650,000—although only 250,000 came under his direct command, with another 120,000 under Nicolas Charles Oudinot and 30,000 under Davout. The remaining imperial forces came mostly from the Confederation of the Rhine, especially Saxony and Bavaria. In addition, to the south, Murat's Kingdom of Naples and Eugène de Beauharnais's Kingdom of Italy had 100,000 armed men. In Spain, another 150,000 to 200,000 French troops steadily retreated before Anglo-Portuguese forces numbering around 100,000. Thus around 900,000 Frenchmen in all theatres faced around 1,800,000 coalition soldiers (including the strategic reserve under formation in Germany). The gross figures may mislead slightly, as most of the German troops fighting on the side of the French fought at best unreliably and stood on the verge of defecting to the Allies. One can reasonably say that Napoleon could count on no more than 450,000 men in Germany—which left him outnumbered about four to one. Following the end of the armistice, Napoleon seemed to have regained the initiative at Dresden (August 1813), where he once again defeated a numerically superior coalition army and inflicted enormous casualties, while sustaining relatively few. The failures of his marshals and a slow resumption of the offensive on his part cost him any advantage that this victory might have secured.
=== MeSH D12.644.468 – opioid peptides === MeSH D12.644.468.180 – dynorphins MeSH D12.644.468.241 – endorphins MeSH D12.644.468.241.030 – alpha-endorphin MeSH D12.644.468.241.080 – beta-endorphin MeSH D12.644.468.241.360 – gamma-endorphin MeSH D12.644.468.281 – enkephalins MeSH D12.644.468.281.075 – enkephalin, ala(2)-mephe(4)-gly(5)- MeSH D12.644.468.281.231 – enkephalin, leucine MeSH D12.644.468.281.231.300 – enkephalin, leucine-2-alanine MeSH D12.644.468.281.381 – enkephalin, methionine MeSH D12.644.468.281.381.300 – d-ala(2),mephe(4),met(0)-ol-enkephalin MeSH D12.644.468.281.600 – enkephalin, d-penicillamine (2,5)-
Sources: en.wikipedia.org
Intranasal administration predominates in both animal and human research because it avoids hepatic first-pass metabolism. Injectable and intraperitoneal routes appear in animal work mainly for comparison.
Behavioral endpoints include time spent in open arms of the elevated plus maze and avoidance latencies. Biochemical endpoints include BDNF concentration, cytokine levels, and monoamine metabolite ratios in brain tissue.
Most published studies are small, originate from a limited number of laboratories, and lack independent replication. Dose-response relationships, measured brain exposure, and long-term outcomes are not well characterized.
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.